The Clorox Company (NYSE:CLX) Shares Acquired by NBC Securities Inc.

NBC Securities Inc. lifted its position in The Clorox Company (NYSE:CLX - Free Report) by 123,850.0% during the first quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 2,479 shares of the company's stock after acquiring an additional 2,477 shares during the period. NBC Securities Inc.'s holdings in Clorox were worth $365,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Several other large investors have also recently made changes to their positions in CLX. Redwood Park Advisors LLC purchased a new position in Clorox in the 4th quarter worth approximately $26,000. Millstone Evans Group LLC purchased a new stake in Clorox in the 4th quarter valued at $31,000. Wood Tarver Financial Group LLC acquired a new stake in shares of Clorox in the 4th quarter worth $31,000. Asset Planning Inc purchased a new position in shares of Clorox during the 4th quarter worth $32,000. Finally, GKV Capital Management Co. Inc. purchased a new position in shares of Clorox during the 4th quarter worth $32,000. 78.53% of the stock is currently owned by hedge funds and other institutional investors.

Clorox Stock Performance

NYSE CLX traded up $0.41 during trading hours on Friday, hitting $127.71. The company had a trading volume of 1,080,790 shares, compared to its average volume of 1,349,584. The Clorox Company has a 1-year low of $126.99 and a 1-year high of $171.37. The company has a debt-to-equity ratio of 20.52, a quick ratio of 0.60 and a current ratio of 0.94. The company has a market cap of $15.74 billion, a PE ratio of 34.89, a price-to-earnings-growth ratio of 2.62 and a beta of 0.54. The business has a 50 day moving average of $136.60 and a 200-day moving average of $149.92.

Clorox (NYSE:CLX - Get Free Report) last posted its quarterly earnings data on Monday, May 5th. The company reported $1.45 earnings per share for the quarter, missing the consensus estimate of $1.57 by ($0.12). The firm had revenue of $1.67 billion during the quarter, compared to analyst estimates of $1.74 billion. Clorox had a net margin of 6.38% and a return on equity of 316.87%. Clorox's revenue was down 8.0% compared to the same quarter last year. During the same period in the previous year, the company posted $1.71 earnings per share. As a group, equities research analysts expect that The Clorox Company will post 7.15 EPS for the current year.

Insider Buying and Selling at Clorox

In other news, Director Pierre R. Breber purchased 4,000 shares of the company's stock in a transaction dated Wednesday, May 7th. The shares were acquired at an average cost of $136.57 per share, for a total transaction of $546,280.00. Following the completion of the purchase, the director now directly owns 4,000 shares in the company, valued at $546,280. The trade was a ∞ increase in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Company insiders own 0.57% of the company's stock.

Wall Street Analysts Forecast Growth

A number of research firms have recently weighed in on CLX. UBS Group lowered their price target on Clorox from $176.00 to $154.00 and set a "neutral" rating for the company in a report on Thursday, April 17th. JPMorgan Chase & Co. decreased their price target on Clorox from $151.00 to $144.00 and set a "neutral" rating on the stock in a research note on Tuesday, May 6th. Evercore ISI set a $140.00 price objective on Clorox and gave the company an "underperform" rating in a research note on Tuesday, May 6th. Morgan Stanley decreased their target price on Clorox from $165.00 to $150.00 and set an "equal weight" rating on the stock in a research note on Tuesday, May 6th. Finally, Citigroup cut their price target on shares of Clorox from $165.00 to $150.00 and set a "neutral" rating on the stock in a research note on Monday, April 14th. Three equities research analysts have rated the stock with a sell rating, ten have given a hold rating and one has issued a buy rating to the company. According to MarketBeat, the stock currently has an average rating of "Hold" and a consensus price target of $151.23.

Clorox Profile

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.